These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11575602)
1. Carnitine-deficient myopathy as a presentation of tyrosinemia type I. Nissenkorn A; Korman SH; Vardi O; Levine A; Katzir Z; Ballin A; Lerman-Sagie T J Child Neurol; 2001 Sep; 16(9):642-4. PubMed ID: 11575602 [TBL] [Abstract][Full Text] [Related]
2. Tyrosinemia type 1 in pediatric nephrology: Not always straightforward. Brito Dos Santos S; Bertholet-Thomas A; Butin M; Dubourg L; Fouilhoux A; Bacchetta J Arch Pediatr; 2021 May; 28(4):338-341. PubMed ID: 33858731 [TBL] [Abstract][Full Text] [Related]
3. Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. Gahl WA; Bernardini I; Dalakas M; Rizzo WB; Harper GS; Hoeg JM; Hurko O; Bernar J J Clin Invest; 1988 Feb; 81(2):549-60. PubMed ID: 3276734 [TBL] [Abstract][Full Text] [Related]
4. Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. Bernardini I; Rizzo WB; Dalakas M; Bernar J; Gahl WA J Clin Invest; 1985 Apr; 75(4):1124-30. PubMed ID: 3988933 [TBL] [Abstract][Full Text] [Related]
5. Nephropathic cystinosis in black children. Case reports. Sochett E; Pettifor JM; Milner L; Thomson PD; Berkowitz F S Afr Med J; 1984 Mar; 65(10):397-8. PubMed ID: 6701696 [TBL] [Abstract][Full Text] [Related]
6. [Myopathy with carnitine deficiency and lactic acidosis. A contribution to differential diagnosis of carnitine deficiency myopathies and mitochondrial myopathies]. Cammann R; Dunker H; Schumacher H; Ruitenbeek W; Sperner J Z Arztl Fortbild (Jena); 1992 Jul; 86(13):667-71. PubMed ID: 1642019 [No Abstract] [Full Text] [Related]
7. Tenofovir as a cause of acquired fanconi's syndrome. Simon M; Meah A Ann Afr Med; 2023; 22(1):128-130. PubMed ID: 36695235 [TBL] [Abstract][Full Text] [Related]
8. Fanconi's syndrome and nephrogenic diabetes insipidus in an adult treated with ifosfamide. Ingemi AI; Bota VM; Peguero A; Charpentier M Pharmacotherapy; 2012 Jan; 32(1):e12-6. PubMed ID: 22392832 [TBL] [Abstract][Full Text] [Related]
9. The various renal manifestations of the nephropathic form of cystinosis. Lemire J; Kaplan BS Am J Nephrol; 1984; 4(2):81-5. PubMed ID: 6720758 [TBL] [Abstract][Full Text] [Related]
10. Multinucleated podocytes in a child with nephrotic syndrome and Fanconi's syndrome: A unique clue to the diagnosis. Bonsib SM; Horvath F Am J Kidney Dis; 1999 Nov; 34(5):966-71. PubMed ID: 10561159 [No Abstract] [Full Text] [Related]
11. Prominent hypophosphatemia due to proximal tubulopathy mimicking Fanconi's syndrome in a patient with obstructive jaundice. Kalambokis G; Milionis HJ; Economou M; Tsianos EV; Elisaf MS Clin Nephrol; 2006 Apr; 65(4):306-7. PubMed ID: 16629234 [No Abstract] [Full Text] [Related]
12. Renal handling of free and acylcarnitine in secondary carnitine deficiency. Ohtani Y; Nishiyama S; Matsuda I Neurology; 1984 Jul; 34(7):977-9. PubMed ID: 6539878 [TBL] [Abstract][Full Text] [Related]
13. [On the clinical aspects and differential diagnosis of Fanconi's syndrome in children]. Zhukovskiĭ MA; Usol'tsev AN Vopr Okhr Materin Det; 1966 Jan; 11(1):87-91. PubMed ID: 5986387 [No Abstract] [Full Text] [Related]
14. [Carnitine deficiency and carnitine therapy]. Künnert B Z Gesamte Inn Med; 1988 Jan; 43(1):1-5. PubMed ID: 3281380 [TBL] [Abstract][Full Text] [Related]
16. Tyrosinemia type 1 and irreversible neurologic crisis after one month discontinuation of nitisone. Önenli Mungan N; Yıldızdaş D; Kör D; Horoz ÖÖ; İncecik F; Öktem M; Sander J Metab Brain Dis; 2016 Oct; 31(5):1181-3. PubMed ID: 27188289 [TBL] [Abstract][Full Text] [Related]
17. [Clinical, biochemical and molecular characteristics in 11 Czech children with tyrosinemia type I]. Vondrácková A; Tesarová M; Magner M; Docekalová D; Chrastina P; Procházkova D; Zeman J; Honzík T Cas Lek Cesk; 2010; 149(9):411-6. PubMed ID: 21117323 [TBL] [Abstract][Full Text] [Related]